✦ LIBER ✦

An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma

✍ Scribed by Fumihiko Kanai, Shuntaro Obi, Shigetoshi Fujiyama…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of sunitinib in pati

✍ Sandrine Faivre; Eric Raymond; Eveline Boucher; Jean Douillard; Ho Y Lim; Jun S 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 178 KB

Phase II, open-label study of brivanib a

✍ Jairo A. Garcia; Lewis R. Roberts 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Phase II study of gemcitabine in patient

✍ Tai-Shen Yang; Yung-Chang Lin; Jen-Shi Chen; Hung-Ming Wang; Chen-Hsu Wang 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 3 views

Efficacy and safety of sorafenib–gemcita

✍ Naqi, Naeem; Ahmad, Shaharyar; Murad, Sohail; Khattak, Javaid 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 136 KB

A Phase II study of irinotecan in patien

✍ Eileen M. O'Reilly; Keith E. Stuart; Pedro M. Sanz-Altamira; Gary K. Schwartz; C 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Phase II open-label study of sunitinib i

✍ Denise A. Yardley, E. Claire Dees, Stephen D. Myers, Sherry Li, Paul Healey, Zhi 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 217 KB